bpc-157 oral liquid vs Injectable BPC-157: Differences, Benefits, and When to Use Eac – Revolution Health & Wellness Best Forms of BPC‑157: Injectable

Treats depression and anxiety

Increlex (mecasermin) is authorized by the European Medicines Agency for the same pediatric severe primary IGFD indication

WADA Prohibition The World Anti-Doping Agency explicitly prohibits AOD-9604 for competitive athletes: Listed under Section S0 (Non-Approved Substances) and S2.2.3 (Growth Hormone Fragments) Prohibited at all times (both in-competition and out-of-competition) No Therapeutic Use Exemptions (TUEs) available Detection methods developed and implemented in anti-doping laboratories worldwide WADAs 2013 statement clarified that AOD-9604 is a substance still under pre-clinical and clinical development and has not been approved for therapeutic use by any government health authority in the world. Research Classification: AOD-9604 is available only for laboratory research use

Grant, R., Berg, J., Mestayer, R., Braidy, N., Bennett, J., Broom, S., & Watson, J

Neither approach helps you make informed decisions about your research